IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.322
EU - Europa 11.088
AS - Asia 3.650
SA - Sud America 525
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 27
OC - Oceania 21
Totale 35.695
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.257
RU - Federazione Russa 3.443
UA - Ucraina 2.802
VN - Vietnam 1.492
GB - Regno Unito 1.186
SE - Svezia 1.109
DE - Germania 991
SG - Singapore 971
CN - Cina 873
FR - Francia 576
BR - Brasile 480
IT - Italia 417
FI - Finlandia 285
KR - Corea 127
PL - Polonia 116
EU - Europa 62
CA - Canada 39
IN - India 38
NL - Olanda 32
HK - Hong Kong 26
BE - Belgio 25
AU - Australia 17
IQ - Iraq 17
BD - Bangladesh 16
IE - Irlanda 16
AT - Austria 14
MX - Messico 14
SA - Arabia Saudita 13
AR - Argentina 11
DK - Danimarca 9
JP - Giappone 9
TR - Turchia 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
VE - Venezuela 8
CO - Colombia 7
ES - Italia 7
PK - Pakistan 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
EC - Ecuador 5
EG - Egitto 5
HR - Croazia 5
IL - Israele 5
BY - Bielorussia 4
HU - Ungheria 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
ID - Indonesia 3
KE - Kenya 3
LT - Lituania 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
CY - Cipro 2
EE - Estonia 2
IM - Isola di Man 2
JO - Giordania 2
LV - Lettonia 2
ME - Montenegro 2
OM - Oman 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
BB - Barbados 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GL - Groenlandia 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MC - Monaco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 35.693
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.971
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Ashburn 1.353
Wilmington 1.310
Seattle 1.083
Cambridge 933
Dearborn 890
Jacksonville 776
Southend 630
Nyköping 614
Boardman 472
Moscow 426
Singapore 394
Beijing 305
Lawrence 258
Princeton 258
Ogden 178
Düsseldorf 137
Shanghai 126
Des Moines 113
Kraków 108
Yubileyny 90
San Diego 88
Los Angeles 85
Bremen 75
The Dalles 71
Grafing 66
Nanjing 62
Jinan 55
London 53
Dallas 42
Hefei 40
New York 40
São Paulo 35
Edinburgh 28
Norwalk 28
Shenyang 27
Brussels 25
Helsinki 25
Kunming 24
Munich 24
San Mateo 24
Hong Kong 22
Napoli 21
Nanchang 20
Rome 19
Amsterdam 18
Auburn Hills 18
Guangzhou 18
Hanover 17
Mirabella Eclano 16
Taiyuan 16
Zhengzhou 16
Santa Clara 15
Chicago 14
Hangzhou 14
Kilburn 14
Hebei 13
Phoenix 13
Belo Horizonte 12
Brooklyn 12
Columbus 12
Montreal 12
Saint Petersburg 12
Chennai 11
Dublin 11
Falls Church 11
Hounslow 11
Tianjin 11
Acton 10
Boston 10
Changsha 10
Curitiba 10
Fuzhou 10
Montemiletto 10
Naples 10
Porto Alegre 10
Rio de Janeiro 10
Riyadh 10
San Francisco 10
Baghdad 9
Copenhagen 9
Frankfurt am Main 9
Seongnam-si 9
Vienna 9
Atlanta 8
Ho Chi Minh City 8
Matawan 8
Ningbo 8
Seo-gu 8
Stockholm 8
Tashkent 8
Campinas 7
Islington 7
Johannesburg 7
Milan 7
Totale 23.592
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 446
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 300
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 238
The good and bad effects of statins on insulin sensitivity and secretion 233
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 229
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 222
Secrezioni ormonali ectopiche 215
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 212
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 205
Effects of physical exercise on the female reproductive system. 198
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 197
Cardiological aspects of growth hormone and insulin-like growth factor-I. 196
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 196
Vitamin D and thyroid disease: to D or not to D? 191
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 190
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 189
Endocrine secretions under abnormal light-dark cycles and in the blind. 186
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 183
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 183
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 183
Failure of long-term therapy with sodium valproate in Cushing's disease. 183
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 182
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 182
Height, weight, height velocity of primary school population sample in Campania region. 181
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 181
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 180
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 180
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 179
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 178
Effects of neridronate treatment in elderly women with osteoporosis 177
Ovulation induction in polycystic ovary syndrome 177
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 177
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 177
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 176
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 175
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 175
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 175
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 174
Lifestyle changes in the management of adulthood and childhood obesity. 174
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 174
Effect of growth hormone on cardiac function. 173
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 173
Adiponectin levels in women with polycystic ovary syndrome 173
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 172
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 172
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 172
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 171
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 171
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 171
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 170
Auditory brainstem responses in thyroid diseases before and after therapy. 170
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 170
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 169
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 169
Growth hormone status in morbidly obese subjects and correlation with body composition 168
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 168
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 168
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 168
Does raloxifene inhibit the growth of uterine fibroids? 167
Circulating ghrelin concentrations in the polycystic ovary syndrome 167
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 167
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 167
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 166
Prevalence of polycystic ovary morphology in a region of South Italy. 166
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 165
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 165
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 165
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 164
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 164
Antisperm antibodies in cryptorchidism before and after surgery. 163
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 163
Terapia di associazione con insulina ed analoghi del GLP-1 163
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 162
Cardiovascular risk of women with polycystic ovary syndrome 162
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 161
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 161
Lymphocyte subset pattern in acromegaly. 161
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 160
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 160
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 160
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 159
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 159
Adrenocortical tumors and insulin resistance. What is the first step? 159
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 158
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 158
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 158
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 158
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 158
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 157
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 157
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 156
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 156
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 155
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. 155
Gut: a key player in the pathogenesis of type 2 diabetes? 155
Evidence for altered adipocyte function in polycystic ovary syndrome. 154
Letter to the Editor: Vitamin D: A Wonder Drug for the Cure of Type 2 Diabetes? 154
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 153
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 153
Thyroid function and morphology after a successful kidney transplantation 152
Totale 17.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.882 395 96 438 184 618 96 525 37 124 440 129 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/2026315 315 0 0 0 0 0 0 0 0 0 0 0
Totale 36.123